BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29636079)

  • 21. DACH1 inhibits the proliferation and migration of papillary thyroid carcinoma.
    Liang S; Xu Q; Liu B; Hu R; Lai J; Wang W; Yu X; Gou J; Wang L; Chen Y; Ji Q; Zhou J
    Cell Biol Int; 2023 Mar; 47(3):612-621. PubMed ID: 36511182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Knockdown of dachshund homolog 1 (DACH1) promotes cell apoptosis and inhibits the invasion and migration abilities of Capan-1 pancreatic cancer cells].
    Bu X; Wang C; Jiang Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Sep; 32(9):1217-22. PubMed ID: 27609579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SOX30 specially prevents Wnt-signaling to suppress metastasis and improve prognosis of lung adenocarcinoma patients.
    Han F; Zhang MQ; Liu WB; Sun L; Hao XL; Yin L; Jiang X; Cao J; Liu JY
    Respir Res; 2018 Dec; 19(1):241. PubMed ID: 30514297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of DACH1 on Proliferation, Invasion, and Apoptosis in Human Lung Adenocarcinoma Cells.
    Yu J; Jiang P; Zhao K; Chen Z; Zuo T; Chen B
    Curr Mol Med; 2021; 21(9):806-811. PubMed ID: 33463463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DACH1 is a novel predictive and prognostic biomarker in hepatocellular carcinoma as a negative regulator of Wnt/β-catenin signaling.
    Liu Y; Zhou R; Yuan X; Han N; Zhou S; Xu H; Guo M; Yu S; Zhang C; Yin T; Wu K
    Oncotarget; 2015 Apr; 6(11):8621-34. PubMed ID: 25940701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of DACH1 on proliferation and invasion of laryngeal squamous cell carcinoma.
    Zhang J; Ren X; Wang B; Cao J; Tian L; Liu M
    Head Face Med; 2018 Sep; 14(1):20. PubMed ID: 30261897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. S100A8/A9 as a risk factor for breast cancer negatively regulated by DACH1.
    Zhang X; Niu M; Li T; Wu Y; Gao J; Yi M; Wu K
    Biomark Res; 2023 Dec; 11(1):106. PubMed ID: 38093319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homozygously deleted gene DACH1 regulates tumor-initiating activity of glioma cells.
    Watanabe A; Ogiwara H; Ehata S; Mukasa A; Ishikawa S; Maeda D; Ueki K; Ino Y; Todo T; Yamada Y; Fukayama M; Saito N; Miyazono K; Aburatani H
    Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12384-9. PubMed ID: 21750150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DACH1, a novel target of miR-218, participates in the regulation of cell viability, apoptosis, inflammatory response, and epithelial-mesenchymal transition process in renal tubule cells treated by high-glucose.
    Zhang YL; Wang JM; Yin H; Wang SB; He CL; Liu J
    Ren Fail; 2020 Nov; 42(1):463-473. PubMed ID: 32408786
    [No Abstract]   [Full Text] [Related]  

  • 30. DACH1 inhibits transforming growth factor-beta signaling through binding Smad4.
    Wu K; Yang Y; Wang C; Davoli MA; D'Amico M; Li A; Cveklova K; Kozmik Z; Lisanti MP; Russell RG; Cvekl A; Pestell RG
    J Biol Chem; 2003 Dec; 278(51):51673-84. PubMed ID: 14525983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alteration of DACH1 methylation patterns in lung cancer contributes to cell proliferation and migration.
    Feng Y; Wang L; Wang M
    Biochem Cell Biol; 2018 Oct; 96(5):602-609. PubMed ID: 29590536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-6807-3p promotes the tumorigenesis of glioma by targeting downstream DACH1.
    Lu GF; Geng F; Xiao Z; Chen YS; Han Y; You CY; Gong NL; Xie ZM; Pan M
    Brain Res; 2019 Apr; 1708():47-57. PubMed ID: 30527681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition.
    Cheng XS; Li YF; Tan J; Sun B; Xiao YC; Fang XB; Zhang XF; Li Q; Dong JH; Li M; Qian HH; Yin ZF; Yang ZB
    Cancer Lett; 2014 Jun; 348(1-2):77-87. PubMed ID: 24657657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth.
    Wu K; Li A; Rao M; Liu M; Dailey V; Yang Y; Di Vizio D; Wang C; Lisanti MP; Sauter G; Russell RG; Cvekl A; Pestell RG
    Mol Cell Biol; 2006 Oct; 26(19):7116-29. PubMed ID: 16980615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CXCL8 gene silencing promotes neuroglial cells activation while inhibiting neuroinflammation through the PI3K/Akt/NF-κB-signaling pathway in mice with ischemic stroke.
    Lv H; Li J; Che YQ
    J Cell Physiol; 2019 May; 234(5):7341-7355. PubMed ID: 30362547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of microRNA‑140‑3p mediates dachshund family transcription factor 1 expression in immunoglobulin A nephropathy through cell cycle‑dependent mechanisms.
    Zhou X; Lu Y; Guo P; Zhou C
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional and posttranscriptional regulation of CXCL8/IL-8 gene expression induced by connective tissue growth factor.
    Lin CH; Wang YH; Chen YW; Lin YL; Chen BC; Chen MC
    Immunol Res; 2016 Apr; 64(2):369-84. PubMed ID: 26071024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma.
    Mo ML; Okamoto J; Chen Z; Hirata T; Mikami I; Bosco-Clément G; Li H; Zhou HM; Jablons DM; He B
    PLoS One; 2013; 8(8):e71816. PubMed ID: 23977152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
    Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
    Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetylation of the cell-fate factor dachshund determines p53 binding and signaling modules in breast cancer.
    Chen K; Wu K; Gormley M; Ertel A; Wang J; Zhang W; Zhou J; Disante G; Li Z; Rui H; Quong AA; McMahon SB; Deng H; Lisanti MP; Wang C; Pestell RG
    Oncotarget; 2013 Jun; 4(6):923-35. PubMed ID: 23798621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.